Burden of chronic kidney disease in Peru: a population-based study
Background: Chronic kidney disease's (CKD) silent progression, association with other chronic diseases, and high treatment costs make it a global public health concern, especially in low-income and middle-income countries (LMIC) where health-care resources are constrained. Understanding CKD ep...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-03-01
|
Series: | The Lancet Global Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214109X15701531 |
id |
doaj-635e27416cdf40c8aa5df52f9733a6a5 |
---|---|
record_format |
Article |
spelling |
doaj-635e27416cdf40c8aa5df52f9733a6a52020-11-25T02:02:57ZengElsevierThe Lancet Global Health2214-109X2015-03-013S1S3410.1016/S2214-109X(15)70153-1Burden of chronic kidney disease in Peru: a population-based studyE R Francis, MPH0C Kuo, MD1A Bernabe-Ortiz, MD2L Nessel, MSS3R Gilman, MD4W Checkley, MD5Dr. J Miranda, MD6H Feldman, MD7the CRONICAS Cohort Study Group8CRONICAS Center of Excellence in Chronic Diseases, Hershey, PA, USAJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USACRONICAS Center of Excellence in Chronic Diseases, Hershey, PA, USADepartment of Biostatistics and Epidemiology at the University of Pennsylvania, Philadelphia, PA, USACRONICAS Center of Excellence in Chronic Diseases, Hershey, PA, USACRONICAS Center of Excellence in Chronic Diseases, Hershey, PA, USACRONICAS Center of Excellence in Chronic Diseases, Hershey, PA, USAPerelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USAUniversidad Peruana Cayetano Heredia, Lima, Peru Background: Chronic kidney disease's (CKD) silent progression, association with other chronic diseases, and high treatment costs make it a global public health concern, especially in low-income and middle-income countries (LMIC) where health-care resources are constrained. Understanding CKD epidemiology in these countries is key to addressing CKD burden and will guide disease surveillance, screening, prevention, and resource allocation. In keeping, this study serves as one of the early descriptions of the CKD burden in Peru. Methods: In this cross-sectional study, we collected baseline demographic data and biological samples to measure markers for CKD, serum creatinine, and urine protein, from 404 participants who were a random subsample of the ongoing CRONICAS cohort study in Lima and Tumbes, Peru. Participants were identified via a single-stage sampling method and stratified by sex and age (35–44; 45–54; 55–64; and ≥65 years). Inclusion required full-time residence in the area, the ability to understand study procedures, and informed consent. Selection of participants continued until age and sex strata were filled. Trained fieldworkers went door-to-door to enrol selected participants and receive written informed consent. We used Poisson regression to identify possible factors associated with CKD. CKD was defined as estimated glomerular filtration rate (eGFR) <60mL/min/1·73m2 or proteinuria (protein-creatinine ratio) ≥150 mg/g creatinine, or both, based on the latest Kidney Disease Improving Global Outcomes (KDIGO) guideline. Findings: Participants' median age was 54·8 years (IQR 44·9–64·8). Of the 404 participants, 68 (16·8%) met the study's CKD criteria: 60 (14·9%) with proteinuria, four (1%) with eGFR <60mL/min/1·73m2, and four (1%) with both. CKD prevalence was higher in Lima than Tumbes (20·7% vs 12·9%, p=0·04). Among participants with CKD, the prevalence of diabetes and hypertension was 19·1% (n= 13) and 42·7% (29), respectively. After multivariable adjustment, CKD was associated with older age, female sex, the highest wealth tertile (although all wealth strata were below the poverty line), living in Lima, diabetes, and hypertension. Interpretation: This study has identified a high prevalence of CKD in our Lima and Tumbes sample groups. Our findings highlight the burden of CKD, much of which is likely occult, and suggest that expanded strategies to measure actual CKD burden through nationwide surveillance efforts are needed. In light of the few therapeutic options to slow CKD progression and low rates of access to health care and insurance in Peru, such expanded surveillance strategies may identify more disease and, therefore, help to prevent disease progression and secondary morbidity. Funding: The CKD study was funded by University of Pennsylvania. The CRONICAS Cohort Study was supported by the National Heart, Lung, and Blood Institute (project number 268200900033C-1-0-1). ERF was supported by WCMC and JHBSPH. http://www.sciencedirect.com/science/article/pii/S2214109X15701531 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
E R Francis, MPH C Kuo, MD A Bernabe-Ortiz, MD L Nessel, MSS R Gilman, MD W Checkley, MD Dr. J Miranda, MD H Feldman, MD the CRONICAS Cohort Study Group |
spellingShingle |
E R Francis, MPH C Kuo, MD A Bernabe-Ortiz, MD L Nessel, MSS R Gilman, MD W Checkley, MD Dr. J Miranda, MD H Feldman, MD the CRONICAS Cohort Study Group Burden of chronic kidney disease in Peru: a population-based study The Lancet Global Health |
author_facet |
E R Francis, MPH C Kuo, MD A Bernabe-Ortiz, MD L Nessel, MSS R Gilman, MD W Checkley, MD Dr. J Miranda, MD H Feldman, MD the CRONICAS Cohort Study Group |
author_sort |
E R Francis, MPH |
title |
Burden of chronic kidney disease in Peru: a population-based study |
title_short |
Burden of chronic kidney disease in Peru: a population-based study |
title_full |
Burden of chronic kidney disease in Peru: a population-based study |
title_fullStr |
Burden of chronic kidney disease in Peru: a population-based study |
title_full_unstemmed |
Burden of chronic kidney disease in Peru: a population-based study |
title_sort |
burden of chronic kidney disease in peru: a population-based study |
publisher |
Elsevier |
series |
The Lancet Global Health |
issn |
2214-109X |
publishDate |
2015-03-01 |
description |
Background: Chronic kidney disease's (CKD) silent progression, association with other chronic diseases, and high treatment costs make it a global public health concern, especially in low-income and middle-income countries (LMIC) where health-care resources are constrained. Understanding CKD epidemiology in these countries is key to addressing CKD burden and will guide disease surveillance, screening, prevention, and resource allocation. In keeping, this study serves as one of the early descriptions of the CKD burden in Peru.
Methods: In this cross-sectional study, we collected baseline demographic data and biological samples to measure markers for CKD, serum creatinine, and urine protein, from 404 participants who were a random subsample of the ongoing CRONICAS cohort study in Lima and Tumbes, Peru. Participants were identified via a single-stage sampling method and stratified by sex and age (35–44; 45–54; 55–64; and ≥65 years). Inclusion required full-time residence in the area, the ability to understand study procedures, and informed consent. Selection of participants continued until age and sex strata were filled. Trained fieldworkers went door-to-door to enrol selected participants and receive written informed consent. We used Poisson regression to identify possible factors associated with CKD. CKD was defined as estimated glomerular filtration rate (eGFR) <60mL/min/1·73m2 or proteinuria (protein-creatinine ratio) ≥150 mg/g creatinine, or both, based on the latest Kidney Disease Improving Global Outcomes (KDIGO) guideline.
Findings: Participants' median age was 54·8 years (IQR 44·9–64·8). Of the 404 participants, 68 (16·8%) met the study's CKD criteria: 60 (14·9%) with proteinuria, four (1%) with eGFR <60mL/min/1·73m2, and four (1%) with both. CKD prevalence was higher in Lima than Tumbes (20·7% vs 12·9%, p=0·04). Among participants with CKD, the prevalence of diabetes and hypertension was 19·1% (n= 13) and 42·7% (29), respectively. After multivariable adjustment, CKD was associated with older age, female sex, the highest wealth tertile (although all wealth strata were below the poverty line), living in Lima, diabetes, and hypertension.
Interpretation: This study has identified a high prevalence of CKD in our Lima and Tumbes sample groups. Our findings highlight the burden of CKD, much of which is likely occult, and suggest that expanded strategies to measure actual CKD burden through nationwide surveillance efforts are needed. In light of the few therapeutic options to slow CKD progression and low rates of access to health care and insurance in Peru, such expanded surveillance strategies may identify more disease and, therefore, help to prevent disease progression and secondary morbidity.
Funding: The CKD study was funded by University of Pennsylvania. The CRONICAS Cohort Study was supported by the National Heart, Lung, and Blood Institute (project number 268200900033C-1-0-1). ERF was supported by WCMC and JHBSPH.
|
url |
http://www.sciencedirect.com/science/article/pii/S2214109X15701531 |
work_keys_str_mv |
AT erfrancismph burdenofchronickidneydiseaseinperuapopulationbasedstudy AT ckuomd burdenofchronickidneydiseaseinperuapopulationbasedstudy AT abernabeortizmd burdenofchronickidneydiseaseinperuapopulationbasedstudy AT lnesselmss burdenofchronickidneydiseaseinperuapopulationbasedstudy AT rgilmanmd burdenofchronickidneydiseaseinperuapopulationbasedstudy AT wcheckleymd burdenofchronickidneydiseaseinperuapopulationbasedstudy AT drjmirandamd burdenofchronickidneydiseaseinperuapopulationbasedstudy AT hfeldmanmd burdenofchronickidneydiseaseinperuapopulationbasedstudy AT thecronicascohortstudygroup burdenofchronickidneydiseaseinperuapopulationbasedstudy |
_version_ |
1724950429376184320 |